China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 3,220 full-time employees. The company went IPO on 2004-12-02. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The firm operates its business in mainland China and Hong Kong markets.
Follow-Up Questions
CSWYF の株価パフォーマンスは？
CSWYF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
China Shineway Pharmaceutical Group Ltd の主な事業テーマや業界は？
China Shineway Pharmaceutical Group Ltd は Pharmaceuticals 業界、セクターは Health Care に属しています。
China Shineway Pharmaceutical Group Ltd の時価総額はいくらですか？
China Shineway Pharmaceutical Group Ltd の現在の時価総額は $0 です。
China Shineway Pharmaceutical Group Ltd は、買い、売り、ホールドのどれですか？
